Stock News

Johnson & Johnson (JNJ) Market Valuation Declined While Amg National Trust Bank Has Lowered Stake; Pros Holdings (PRO) Holder Sagard Capital Partners Management Has Trimmed Stake by $23.63 Million as Shares Rose

Johnson & Johnson (NYSE:JNJ) Logo

Dan Friedberg decreased its stake in Pros Holdings Inc (PRO) by 66.72% based on its latest 2018Q1 regulatory filing with the SEC. Sagard Capital Partners Management Corp sold 715,950 shares as the company’s stock rose 12.46% while stock markets declined. The hedge fund run by Dan Friedberg held 357,143 shares of the technology company at the end of 2018Q1, valued at $11.79 million, down from 1.07M at the end of the previous reported quarter. Sagard Capital Partners Management Corp who had been investing in Pros Holdings Inc for a number of months, seems to be less bullish one the $1.22 billion market cap company. The stock increased 1.85% or $0.68 during the last trading session, reaching $37.39. About 163,677 shares traded. PROS Holdings, Inc. (NYSE:PRO) has risen 19.83% since June 18, 2017 and is uptrending. It has outperformed by 7.26% the S&P500. Some Historical PRO News: 18/04/2018 – PROS Thought Leaders Selected to Deliver Presentations at Professional Pricing Society Spring Conference; 10/04/2018 – PROS Announces Participation in Hannover Messe; 26/04/2018 – PROS Holdings 1Q Adj Loss/Shr 19c; 16/05/2018 – SAP and PROS Team up to Provide One-Stop Commerce and Merchandising Solution for Airlines; 26/04/2018 – PROS HOLDINGS INC – QTRLY NET LOSS PER SHARE $0.58; 21/04/2018 – DJ PROS Holdings Inc, Inst Holders, 1Q 2018 (PRO); 30/04/2018 – PROS Scientists to Present Revenue Management Research at POMS 2018 Conference; 27/04/2018 – PROS HOLDINGS INC PRO.N : JP MORGAN RAISES TARGET PRICE TO $38 FROM $34; 10/04/2018 – CLEARLAKE CAPITAL BUYS WHEEL PROS, TERMS NOT DISCLOSED; 13/03/2018 – PROS: PROS Adrienne Collins loved talking #AI in business travel with other Travel experts at @Egencia’s Lunch and Learns…

Amg National Trust Bank decreased its stake in Johnson & Johnson (JNJ) by 70.35% based on its latest 2018Q1 regulatory filing with the SEC. Amg National Trust Bank sold 12,150 shares as the company’s stock declined 8.03% with the market. The institutional investor held 5,122 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $656,000, down from 17,272 at the end of the previous reported quarter. Amg National Trust Bank who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $328.86 billion market cap company. The stock increased 0.16% or $0.2 during the last trading session, reaching $122.61. About 13.17 million shares traded or 99.03% up from the average. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 18, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 23/05/2018 – ADVISORY: JJ RUEST, CN INTERIM PRESIDENT, CEO, TO ADDRESS; 11/04/2018 – Johnson & Johnson Required to Pay Damages of $80 Million in Lawsuit Involving Baby Powder; 04/04/2018 – J&J Jury Set to Weigh Banker’s Claims Baby Powder Caused Cancer; 16/03/2018 – J&J – RECEIVED A BINDING OFFER FROM PLATINUM EQUITY, A LEADING PRIVATE INVESTMENT FIRM, TO ACQUIRE ITS LIFESCAN BUSINESS FOR APPROXIMATELY $2.1 BLN; 16/03/2018 – JOHNSON & JOHNSON: BINDING OFFER FROM PLATINUM EQUITY TO BUY; 16/03/2018 – J&J REPORTS BINDING OFFER FROM PLATINUM EQUITY TO BUY LIFESCAN,; 07/03/2018 – Johnson & Johnson Vision Advocates on Behalf of Patients at FTC Public Workshop; 16/03/2018 – Johnson & Johnson Gets Binding Offer for LifeScan Unit From Platinum Equity; 09/03/2018 – STAT Plus: Pharmalittle: J&J says average prices paid for its drugs declined; feds will use false claims to crack down on opioid abuse; 18/04/2018 – Johnson & Johnson/biosimilars: immune to reason

Analysts await PROS Holdings, Inc. (NYSE:PRO) to report earnings on August, 2. They expect $-0.34 EPS, up 2.86% or $0.01 from last year’s $-0.35 per share. After $-0.37 actual EPS reported by PROS Holdings, Inc. for the previous quarter, Wall Street now forecasts -8.11% EPS growth.

Another recent and important PROS Holdings, Inc. (NYSE:PRO) news was published by Businesswire.com which published an article titled: “PROS Holdings, Inc. to Present at Stifel 2018 Cross Sector Insight Conference” on June 05, 2018.

Since February 14, 2018, it had 0 insider buys, and 4 selling transactions for $1.96 million activity.

Investors sentiment decreased to 1.1 in Q1 2018. Its down 0.27, from 1.37 in 2017Q4. It fall, as 8 investors sold PRO shares while 34 reduced holdings. 15 funds opened positions while 31 raised stakes. 31.16 million shares or 0.66% less from 31.37 million shares in 2017Q4 were reported. The California-based Wells Fargo Mn has invested 0% in PROS Holdings, Inc. (NYSE:PRO). Kornitzer Cap Mngmt Ks holds 0.09% of its portfolio in PROS Holdings, Inc. (NYSE:PRO) for 152,130 shares. Fmr Limited Company holds 1.21 million shares. Morgan Stanley reported 0% in PROS Holdings, Inc. (NYSE:PRO). Conestoga Cap Advsr Ltd Limited Liability Company has invested 2.36% in PROS Holdings, Inc. (NYSE:PRO). Rhumbline Advisers owns 24,660 shares. Waddell And Reed Fincl Inc holds 0.04% or 483,350 shares in its portfolio. Moreover, Parametric Assocs Lc has 0% invested in PROS Holdings, Inc. (NYSE:PRO) for 33,643 shares. Fruth Management holds 8,900 shares or 0.13% of its portfolio. Whetstone Cap Advisors Ltd Limited Liability Company invested 9.76% in PROS Holdings, Inc. (NYSE:PRO). Brown Cap Mngmt Limited Liability Com reported 4.88M shares or 1.83% of all its holdings. Geode Cap Limited Liability Com has invested 0% in PROS Holdings, Inc. (NYSE:PRO). Us Bancshares De has invested 0% in PROS Holdings, Inc. (NYSE:PRO). Fred Alger Management has 238,677 shares for 0.04% of their portfolio. Stifel Financial holds 0% or 26,591 shares.

Among 10 analysts covering Pros Holdings (NYSE:PRO), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Pros Holdings had 22 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by KeyBanc Capital Markets on Tuesday, May 8 with “Overweight”. The rating was downgraded by JMP Securities on Friday, August 7 to “Mkt Outperform”. Needham maintained it with “Buy” rating and $35.0 target in Monday, October 23 report. The rating was maintained by KeyBanc Capital Markets on Thursday, April 12 with “Buy”. The stock of PROS Holdings, Inc. (NYSE:PRO) has “Hold” rating given on Friday, August 4 by Stifel Nicolaus. Needham maintained PROS Holdings, Inc. (NYSE:PRO) rating on Tuesday, September 12. Needham has “Buy” rating and $35.0 target. As per Monday, May 21, the company rating was upgraded by Northland Capital. The firm has “Buy” rating by Needham given on Thursday, February 23. The stock of PROS Holdings, Inc. (NYSE:PRO) earned “Hold” rating by Northland Capital on Friday, October 27. Stifel Nicolaus maintained PROS Holdings, Inc. (NYSE:PRO) on Friday, October 6 with “Hold” rating.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.06 EPS, up 12.57% or $0.23 from last year’s $1.83 per share. JNJ’s profit will be $5.53 billion for 14.88 P/E if the $2.06 EPS becomes a reality. After $2.06 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Congo begins Ebola vaccinations” on May 21, 2018, also Seekingalpha.com with their article: “Avoiding The ‘Black Hole’ Of Disease Development” published on June 15, 2018, Seekingalpha.com published: “Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)” on June 12, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: “Better Buy: Verizon Communications Inc. vs. Johnson & Johnson” published on June 11, 2018 as well as Nasdaq.com‘s news article titled: “Better Buy: Johnson & Johnson vs. Eli Lilly” with publication date: June 17, 2018.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Buy” rating by Credit Suisse on Thursday, October 19. The stock of Johnson & Johnson (NYSE:JNJ) has “Equal-Weight” rating given on Wednesday, October 18 by Barclays Capital. As per Friday, July 14, the company rating was maintained by Jefferies. Stifel Nicolaus maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, January 24 with “Hold” rating. Barclays Capital maintained the stock with “Overweight” rating in Wednesday, April 20 report. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Jefferies on Thursday, August 4. The stock has “Outperform” rating by Cowen & Co on Tuesday, August 25. The rating was upgraded by Wells Fargo on Monday, October 9 to “Buy”. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Wednesday, October 18 by Leerink Swann. The stock has “Neutral” rating by JP Morgan on Tuesday, January 2.

Amg National Trust Bank, which manages about $1.55 billion US Long portfolio, upped its stake in Ishares (EEM) by 10,164 shares to 89,011 shares, valued at $4.30 million in 2018Q1, according to the filing. It also increased its holding in Spdr (SPY) by 19,744 shares in the quarter, for a total of 605,145 shares, and has risen its stake in Vanguard (VTI).

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *